What SABR dose-fractionation would you use when treating an oligometastatic site in the femur or weight-bearing acetabulum?  

The COMET trial excluded femur sites.



Answer from: Radiation Oncologist at Academic Institution
Comments
Radiation Oncologist at Mon Health
Do you have a lesion size limitation?
Sign in or Register to read more